Description of Hospitalization Episodes of All-Cause Pneumonia and Nonbacteremic Pneumococcal Pneumonia in Terms of Patient Characteristics in France, Annual Average 2013–2019
| Characteristic . | All-Cause Pneumonia . | NBPP . |
|---|---|---|
| All adults | ||
| Mean No. of episodes (SD) | 314 177 (17 818.62) | 10 041 (1250.68) (3.2% of all-cause pneumonia) |
| Sex, male | 168 705 (53.7) | 5828 (58.0) |
| Age | ||
| 18–49 y | 30 637 (9.7) | 1587 (15.8) |
| 50–64 y | 49 301 (15.7) | 2384 (23.7) |
| ≥65 y | 234 238 (74.5) | 6071 (60.5) |
| Age, y, median (IQR) | ||
| All adults | 78 (64.0–87.0) | 69 (57.0–82.0) |
| Low risk | 78 (61.0–87.0) | 67 (52–82) |
| Moderate risk | 81 (70.0–87.0) | 75 (63.0–84.0) |
| High risk | 67 (57.0–76.0) | 64 (54.0–73.0) |
| Risk group | ||
| Low risk | 154 788 (49.3) | 5330 (53.1) |
| Moderate risk | 121 764 (38.8) | 3573 (35.6) |
| High risk | 37 624 (12.0) | 1138 (11.3) |
| Comorbidities | ||
| Chronic respiratory diseasea | 50 985 (16.2) | 1859 (18.5) |
| Heart failure | 60 180 (19.2) | 1305 (13.0) |
| Diabetes | 54 351 (17.3) | 1504 (15.0) |
| 18–49 y | ||
| Risk group | ||
| Low risk | 20 970 (68.4) | 1148 (72.4) |
| Moderate risk | 4484 (14.6) | 231 (14.5) |
| High risk | 5183 (16.9) | 208 (13.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 2273 (7.4) | 119 (7.5) |
| Heart failure | 833 (2.7) | 35 (2.2) |
| Diabetes | 1463 (4.8) | 69 (4.3) |
| 50–64 y | ||
| Risk group | ||
| Low risk | 23 913 (48.5) | 1243 (52.1) |
| Moderate risk | 14 468 (29.3) | 757 (31.8) |
| High risk | 10 920 (22.1) | 384 (16.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 8732 (17.7) | 473 (19.8) |
| Heart failure | 3903 (7.9) | 151 (6.3) |
| Diabetes | 7333 (14.9) | 320 (13.4) |
| ≥65 y | ||
| Risk group | ||
| Low risk | 109 906 (46.9) | 2939 (48.4) |
| Moderate risk | 102 812 (43.9) | 2585 (42.6) |
| High risk | 21 521 (9.2) | 547 (9.0) |
| Comorbidities | ||
| Chronic respiratory diseasea | 39 979 (17.1) | 1268 (20.9) |
| Heart failure | 55 444 (23.7) | 1119 (18.4) |
| Diabetes | 45 555 (19.4) | 1116 (18.4) |
| Characteristic . | All-Cause Pneumonia . | NBPP . |
|---|---|---|
| All adults | ||
| Mean No. of episodes (SD) | 314 177 (17 818.62) | 10 041 (1250.68) (3.2% of all-cause pneumonia) |
| Sex, male | 168 705 (53.7) | 5828 (58.0) |
| Age | ||
| 18–49 y | 30 637 (9.7) | 1587 (15.8) |
| 50–64 y | 49 301 (15.7) | 2384 (23.7) |
| ≥65 y | 234 238 (74.5) | 6071 (60.5) |
| Age, y, median (IQR) | ||
| All adults | 78 (64.0–87.0) | 69 (57.0–82.0) |
| Low risk | 78 (61.0–87.0) | 67 (52–82) |
| Moderate risk | 81 (70.0–87.0) | 75 (63.0–84.0) |
| High risk | 67 (57.0–76.0) | 64 (54.0–73.0) |
| Risk group | ||
| Low risk | 154 788 (49.3) | 5330 (53.1) |
| Moderate risk | 121 764 (38.8) | 3573 (35.6) |
| High risk | 37 624 (12.0) | 1138 (11.3) |
| Comorbidities | ||
| Chronic respiratory diseasea | 50 985 (16.2) | 1859 (18.5) |
| Heart failure | 60 180 (19.2) | 1305 (13.0) |
| Diabetes | 54 351 (17.3) | 1504 (15.0) |
| 18–49 y | ||
| Risk group | ||
| Low risk | 20 970 (68.4) | 1148 (72.4) |
| Moderate risk | 4484 (14.6) | 231 (14.5) |
| High risk | 5183 (16.9) | 208 (13.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 2273 (7.4) | 119 (7.5) |
| Heart failure | 833 (2.7) | 35 (2.2) |
| Diabetes | 1463 (4.8) | 69 (4.3) |
| 50–64 y | ||
| Risk group | ||
| Low risk | 23 913 (48.5) | 1243 (52.1) |
| Moderate risk | 14 468 (29.3) | 757 (31.8) |
| High risk | 10 920 (22.1) | 384 (16.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 8732 (17.7) | 473 (19.8) |
| Heart failure | 3903 (7.9) | 151 (6.3) |
| Diabetes | 7333 (14.9) | 320 (13.4) |
| ≥65 y | ||
| Risk group | ||
| Low risk | 109 906 (46.9) | 2939 (48.4) |
| Moderate risk | 102 812 (43.9) | 2585 (42.6) |
| High risk | 21 521 (9.2) | 547 (9.0) |
| Comorbidities | ||
| Chronic respiratory diseasea | 39 979 (17.1) | 1268 (20.9) |
| Heart failure | 55 444 (23.7) | 1119 (18.4) |
| Diabetes | 45 555 (19.4) | 1116 (18.4) |
Data are presented as No. (%).
Abbreviations: IQR, interquartile range; NBPP, nonbacteremic pneumococcal pneumonia; SD, standard deviation.
aChronic obstructive pulmonary disease, emphysema.
Description of Hospitalization Episodes of All-Cause Pneumonia and Nonbacteremic Pneumococcal Pneumonia in Terms of Patient Characteristics in France, Annual Average 2013–2019
| Characteristic . | All-Cause Pneumonia . | NBPP . |
|---|---|---|
| All adults | ||
| Mean No. of episodes (SD) | 314 177 (17 818.62) | 10 041 (1250.68) (3.2% of all-cause pneumonia) |
| Sex, male | 168 705 (53.7) | 5828 (58.0) |
| Age | ||
| 18–49 y | 30 637 (9.7) | 1587 (15.8) |
| 50–64 y | 49 301 (15.7) | 2384 (23.7) |
| ≥65 y | 234 238 (74.5) | 6071 (60.5) |
| Age, y, median (IQR) | ||
| All adults | 78 (64.0–87.0) | 69 (57.0–82.0) |
| Low risk | 78 (61.0–87.0) | 67 (52–82) |
| Moderate risk | 81 (70.0–87.0) | 75 (63.0–84.0) |
| High risk | 67 (57.0–76.0) | 64 (54.0–73.0) |
| Risk group | ||
| Low risk | 154 788 (49.3) | 5330 (53.1) |
| Moderate risk | 121 764 (38.8) | 3573 (35.6) |
| High risk | 37 624 (12.0) | 1138 (11.3) |
| Comorbidities | ||
| Chronic respiratory diseasea | 50 985 (16.2) | 1859 (18.5) |
| Heart failure | 60 180 (19.2) | 1305 (13.0) |
| Diabetes | 54 351 (17.3) | 1504 (15.0) |
| 18–49 y | ||
| Risk group | ||
| Low risk | 20 970 (68.4) | 1148 (72.4) |
| Moderate risk | 4484 (14.6) | 231 (14.5) |
| High risk | 5183 (16.9) | 208 (13.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 2273 (7.4) | 119 (7.5) |
| Heart failure | 833 (2.7) | 35 (2.2) |
| Diabetes | 1463 (4.8) | 69 (4.3) |
| 50–64 y | ||
| Risk group | ||
| Low risk | 23 913 (48.5) | 1243 (52.1) |
| Moderate risk | 14 468 (29.3) | 757 (31.8) |
| High risk | 10 920 (22.1) | 384 (16.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 8732 (17.7) | 473 (19.8) |
| Heart failure | 3903 (7.9) | 151 (6.3) |
| Diabetes | 7333 (14.9) | 320 (13.4) |
| ≥65 y | ||
| Risk group | ||
| Low risk | 109 906 (46.9) | 2939 (48.4) |
| Moderate risk | 102 812 (43.9) | 2585 (42.6) |
| High risk | 21 521 (9.2) | 547 (9.0) |
| Comorbidities | ||
| Chronic respiratory diseasea | 39 979 (17.1) | 1268 (20.9) |
| Heart failure | 55 444 (23.7) | 1119 (18.4) |
| Diabetes | 45 555 (19.4) | 1116 (18.4) |
| Characteristic . | All-Cause Pneumonia . | NBPP . |
|---|---|---|
| All adults | ||
| Mean No. of episodes (SD) | 314 177 (17 818.62) | 10 041 (1250.68) (3.2% of all-cause pneumonia) |
| Sex, male | 168 705 (53.7) | 5828 (58.0) |
| Age | ||
| 18–49 y | 30 637 (9.7) | 1587 (15.8) |
| 50–64 y | 49 301 (15.7) | 2384 (23.7) |
| ≥65 y | 234 238 (74.5) | 6071 (60.5) |
| Age, y, median (IQR) | ||
| All adults | 78 (64.0–87.0) | 69 (57.0–82.0) |
| Low risk | 78 (61.0–87.0) | 67 (52–82) |
| Moderate risk | 81 (70.0–87.0) | 75 (63.0–84.0) |
| High risk | 67 (57.0–76.0) | 64 (54.0–73.0) |
| Risk group | ||
| Low risk | 154 788 (49.3) | 5330 (53.1) |
| Moderate risk | 121 764 (38.8) | 3573 (35.6) |
| High risk | 37 624 (12.0) | 1138 (11.3) |
| Comorbidities | ||
| Chronic respiratory diseasea | 50 985 (16.2) | 1859 (18.5) |
| Heart failure | 60 180 (19.2) | 1305 (13.0) |
| Diabetes | 54 351 (17.3) | 1504 (15.0) |
| 18–49 y | ||
| Risk group | ||
| Low risk | 20 970 (68.4) | 1148 (72.4) |
| Moderate risk | 4484 (14.6) | 231 (14.5) |
| High risk | 5183 (16.9) | 208 (13.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 2273 (7.4) | 119 (7.5) |
| Heart failure | 833 (2.7) | 35 (2.2) |
| Diabetes | 1463 (4.8) | 69 (4.3) |
| 50–64 y | ||
| Risk group | ||
| Low risk | 23 913 (48.5) | 1243 (52.1) |
| Moderate risk | 14 468 (29.3) | 757 (31.8) |
| High risk | 10 920 (22.1) | 384 (16.1) |
| Comorbidities | ||
| Chronic respiratory diseasea | 8732 (17.7) | 473 (19.8) |
| Heart failure | 3903 (7.9) | 151 (6.3) |
| Diabetes | 7333 (14.9) | 320 (13.4) |
| ≥65 y | ||
| Risk group | ||
| Low risk | 109 906 (46.9) | 2939 (48.4) |
| Moderate risk | 102 812 (43.9) | 2585 (42.6) |
| High risk | 21 521 (9.2) | 547 (9.0) |
| Comorbidities | ||
| Chronic respiratory diseasea | 39 979 (17.1) | 1268 (20.9) |
| Heart failure | 55 444 (23.7) | 1119 (18.4) |
| Diabetes | 45 555 (19.4) | 1116 (18.4) |
Data are presented as No. (%).
Abbreviations: IQR, interquartile range; NBPP, nonbacteremic pneumococcal pneumonia; SD, standard deviation.
aChronic obstructive pulmonary disease, emphysema.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
